A Multi-centre, Double-blinded, Placebo-controlled, Randomised, Phase II Clinical Trial for Psilocybin-assisted Therapy for Alcohol Use Disorder
Untersuchung der Wirksamkeit einer Psilocybin-gestützten Therapie zur Reduzierung des Alkoholkonsums in einer doppelblinden, randomisierten klinischen Phase-II-Studie.
- Status
- unknown
- Phase
- Phase 2
- Institution
- University of Sydney
- Principal investigator
- Paul Haber, PhD
- Start date
- 2024-09-01
- End date
- 2025-12-01
- Registry ID
- NCT06444243
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.